Search

The article offers information the use of statin drugs for cardiovascular benefits, where scientists and critics are concerned regarding their increasing usage. It highlights the benefits of cholesterol and the emergence of these drugs which were devised to combat excess cholesterol in the arteries. Topics discussed include primary care for heart attacks, insurance policy regarding the matter and effects of the drugs which include mortality, muscle pain and weakness.

This largest-to-date analysis of six randomized studies of ST-elevation myocardial infarction revealed no association between body mass index and infarct size, one-year mortality, or heart failure hospitalization. [ABSTRACT FROM AUTHOR]

Findings were similar when restricted to patients at high CV risk, in younger versus older adults (<65 years vs >=65 years) and based on prior OAB medication. The risk of adverse cardiovascular (CV) events in patients with overactive bladder (OAB) does not appear to be increased with mirabegron compared with muscarinic antagonists, according to findings of the Astellas Pharma-funded Mirabegron PMR-PASS [1] study published in I Drug Safety i . Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study Drug Safety: 8 Jul 2021. [Extracted from the article]

A reprint of the article "Determining myocardial infarction after percutaneous coronary intervention: creatine kinase- myocardial band (PCI: CK-MB), troponin, both, or neither?," by Drs. Pierluigi Tricoci and Sergio Leonardi that was published by Biomarkers Cardiosource.org on October 10, 2013 is presented. It discusses the assessment of cardiac troponins (cTn) value as specific markers for myocardial infarction (MI), necrosis diagnosis after PCI and the mortality risks related to CK-MB.

This section offers news briefs on nutrition research including Australian research showing that increasing fruit and vegetable intake could make people happier, a Harvard research which shows that eating higher amounts of unsaturated fats is linked with lower mortality, and a meta-analysis of 19 studies showing that eating omega-3s from both seafood and plant sources could lower the risk of heart attack mortality.

The article discusses a proposal by the U.S. Centers for Medicare & Medicaid Services (CMS) to put three episodes of care under mandatory experiments with bundled payments. It discusses the nature of care in the proposal such as the treatment for acute myocardial infarction or heart attack, coronary artery bypass grafts, and treatment for hip or femoral fractures. Also offered also is comment from Dr. James Caillouette of Hoag Orthopedic Institute in Irvine, California, on the CMS proposal.

The article reports that greater intake of dietary fiber enhances glycemic response and insulin sensitivity which lower the risk of cardiovascular disease and diabetes, adding that cereal fiber is also associated with the decreased risk of mortality after surviving a heart attack. Study findings show that after a first attack, patients who adhere to dietary guidelines have a better outcome of living longer. Dietary changes, however, have not been used to advise the prevention of repeat attacks. INSET: FIBER FACTS.